-+ 0.00%
-+ 0.00%
-+ 0.00%

OCULIS ANNOUNCES POSITIVE FDA PRE-IND FEEDBACK SUPPORTING PRIVOSEGTOR DEVELOPMENT STRATEGY FOR TREATMENT OF ACUTE MULTIPLE SCLEROSIS RELAPSES

Reuters·08/03/2026 08:00:00

Please log in to view news